These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of liver resection and radiofrequency ablation in long-term survival among patients with early-stage hepatocellular carcinoma: a meta-analysis of randomized trials and high-quality propensity score-matched studies. Hu L, Lin J, Wang A, Shi X, Qiao Y. World J Surg Oncol; 2024 Feb 19; 22(1):56. PubMed ID: 38369480 [Abstract] [Full Text] [Related]
5. Surgical Resection Versus Radiofrequency Ablation for Single Hepatocellular Carcinoma ≤ 2 cm in a Propensity Score Model. Liu PH, Hsu CY, Hsia CY, Lee YH, Huang YH, Chiou YY, Lin HC, Huo TI. Ann Surg; 2016 Mar 19; 263(3):538-45. PubMed ID: 25775062 [Abstract] [Full Text] [Related]
6. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection. Wang G, Zhang W, Tan Y, Jiang L, Yang J, Yang J, Yan L. Int J Surg; 2019 Dec 19; 72():1-6. PubMed ID: 31610283 [Abstract] [Full Text] [Related]
8. Radiofrequency ablation versus resection for the treatment of early stage hepatocellular carcinoma: a multicenter Australian study. Gory I, Fink M, Bell S, Gow P, Nicoll A, Knight V, Dev A, Rode A, Bailey M, Cheung W, Kemp W, Roberts SK, Melbourne Liver Group. Scand J Gastroenterol; 2015 May 19; 50(5):567-76. PubMed ID: 25615260 [Abstract] [Full Text] [Related]
9. Factors predicting long-term outcomes of early-stage hepatocellular carcinoma after primary curative treatment: the role of surgical or nonsurgical methods. Kuo MJ, Mo LR, Chen CL. BMC Cancer; 2021 Mar 08; 21(1):250. PubMed ID: 33685409 [Abstract] [Full Text] [Related]
14. Surgery versus radiofrequency ablation in patients with Child- Pugh class-A/single small (≤3 cm) hepatocellular carcinoma. Lee J, Jin YJ, Shin SK, Kwon JH, Kim SG, Suh YJ, Jeong Y, Yu JH, Lee JW, Kwon OS, Nahm SW, Kim YS. Clin Mol Hepatol; 2022 Apr 08; 28(2):207-218. PubMed ID: 34814239 [Abstract] [Full Text] [Related]
18. Survival benefit of radiofrequency ablation for solitary (3-5 cm) hepatocellular carcinoma: An analysis for nationwide cancer registry. Lee SH, Jin YJ, Lee JW. Medicine (Baltimore); 2017 Nov 08; 96(44):e8486. PubMed ID: 29095307 [Abstract] [Full Text] [Related]
19. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection. Feng Y, Wu H, Huang DQ, Xu C, Zheng H, Maeda M, Zhao X, Wang L, Xiao F, Lv H, Liu T, Qi J, Li J, Zhong N, Wang C, Feng H, Liang B, Ren W, Qin C, Nguyen MH, Zhu Q. Eur Radiol; 2020 Nov 08; 30(11):6357-6368. PubMed ID: 32529568 [Abstract] [Full Text] [Related]
20. Surgical resection versus radiofrequency ablation for Barcelona Clinic Liver Cancer very early stage hepatocellular carcinoma: long-term results of a single-center study. Hsiao CY, Hu RH, Ho CM, Wu YM, Lee PH, Ho MC. Am J Surg; 2020 Oct 08; 220(4):958-964. PubMed ID: 32247523 [Abstract] [Full Text] [Related] Page: [Next] [New Search]